Fumin Lin received his PhD from Duke University in 2011. He completed his postdoctoral training in National Institute of Environmental Health Sciences and Baylor College of Medicine. In 2015, he joined the Division of Genomic Diagnostics at the Children’s Hospital of Philadelphia (CHOP), where he contributed to the clinical case analysis and assay development for cancer molecular tests, SNP array and constitutional exome as a clinical genomic scientist. He was accepted by the Laboratory Genetics and Genomics Fellowship Program at CHOP in 2018 and completed the training in 2021. In July 2021, he joined the Department of Pathology and Laboratory Medicine at UCLA as an assistant clinical professor. His research interests lie in understanding the molecular mechanisms in various malignancies and utilizing mutation signatures in cancer diagnosis.